ViewMind is a medical and technological startup developing Cognitive Digital Biomarkers.

In a 20-minute, non-invasive, cost-effective and scalable evaluation, ViewMind can detect diseases such as Alzheimer’s, up to 20 years in advance and with over 95% accuracy.

Using a Virtual Reality equipment and eye-tracking technology, intelligent ViewMind algorithms can measure cognitive performance in healthy and sick patients, helping to diagnose and treat diseases such as Parkinson’s, Multiple Sclerosis, Depression or the cognitive effects of COVID- 19, among others.

Clinically validated, approved for medical use, and having achieved a global partnership with Hewlett Packard, ViewMind is positioned for rapid growth.